Duopharma relooks M&A opportunities to remain relevant and expand

Duopharma Biotech group managing director Leonard Ariff Abdul Shatar

KUALA LUMPUR: Duopharma Biotech Bhd will resume looking at mergers and acquisitions (M&A) opportunities especially within ASEAN to remain relevant over the longer term and grow.

Group managing director Leonard Ariff Abdul Shatar said the company has been relatively successful in penetrating the Malaysian market with a market share of seven per cent despite being the largest manufacturer.